Takeda Pharmaceutical Co base_Aktie

Takeda Pharmaceutical Co base_Umsatz 2025

Takeda Pharmaceutical Co base_Umsatz

4,58 number_format_bio JPY

components_StockPageHeader__3

4502.T

components_StockPageHeader__4

JP3463000004

components_StockPageHeader__5

853849

pages_kennzahlen_[key]_[isin]__46

pages_kennzahlen_[key]_[isin]__70

components_DataTable__24components_DataTable__0components_DataTable__2
2028e4,7163,72
2027e4,6464,68
2026e4,6065,20
20254,5865,51
20244,2666,54
20234,0369,11
20223,5768,99
20213,2068,91
20203,2966,89
20192,1068,92
20181,7771,99
20171,7367,74
20161,8170,38
20151,7870,70
20141,6971,02
20131,5671,26
20121,5171,29
20111,4277,63
20101,4780,55
20091,5481,18
20081,3779,73
20071,3178,57
20061,2176,73

components_charts_RevenueChart_0

  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_10y

  • components_charts_BaseChart_0

  • chart_toolbar_max

components_charts_RevenueChart_8
components_charts_RevenueChart_10
components_charts_RevenueChart_9
components_charts_RevenueChart_13

Takeda Pharmaceutical Co components_charts_RevenueChart_15

components_charts_RevenueChart_14Takeda Pharmaceutical Co components_charts_RevenueChart_8Takeda Pharmaceutical Co components_charts_RevenueChart_10Takeda Pharmaceutical Co components_charts_RevenueChart_9
2028e4,71 number_format_bio undefined0 undefined0 undefined
2027e4,64 number_format_bio undefined503,99 number_format_mrd undefined287,02 number_format_mrd undefined
2026e4,60 number_format_bio undefined401,98 number_format_mrd undefined234,02 number_format_mrd undefined
20254,58 number_format_bio undefined342,59 number_format_mrd undefined107,93 number_format_mrd undefined
20244,26 number_format_bio undefined430,79 number_format_mrd undefined144,07 number_format_mrd undefined
20234,03 number_format_bio undefined550,90 number_format_mrd undefined317,02 number_format_mrd undefined
20223,57 number_format_bio undefined545,49 number_format_mrd undefined230,06 number_format_mrd undefined
20213,20 number_format_bio undefined335,72 number_format_mrd undefined376,01 number_format_mrd undefined
20203,29 number_format_bio undefined286,50 number_format_mrd undefined44,24 number_format_mrd undefined
20192,10 number_format_bio undefined183,49 number_format_mrd undefined135,19 number_format_mrd undefined
20181,77 number_format_bio undefined202,84 number_format_mrd undefined186,89 number_format_mrd undefined
20171,73 number_format_bio undefined191,25 number_format_mrd undefined114,94 number_format_mrd undefined
20161,81 number_format_bio undefined147,16 number_format_mrd undefined80,17 number_format_mrd undefined
20151,78 number_format_bio undefined88,69 number_format_mrd undefined-145,78 number_format_mrd undefined
20141,69 number_format_bio undefined151,73 number_format_mrd undefined106,66 number_format_mrd undefined
20131,56 number_format_bio undefined122,51 number_format_mrd undefined131,24 number_format_mrd undefined
20121,51 number_format_bio undefined265,03 number_format_mrd undefined124,16 number_format_mrd undefined
20111,42 number_format_bio undefined367,08 number_format_mrd undefined247,87 number_format_mrd undefined
20101,47 number_format_bio undefined420,21 number_format_mrd undefined297,74 number_format_mrd undefined
20091,54 number_format_bio undefined306,47 number_format_mrd undefined234,39 number_format_mrd undefined
20081,37 number_format_bio undefined423,12 number_format_mrd undefined355,45 number_format_mrd undefined
20071,31 number_format_bio undefined458,50 number_format_mrd undefined335,81 number_format_mrd undefined
20061,21 number_format_bio undefined402,81 number_format_mrd undefined312,90 number_format_mrd undefined

components_charts_MarginsChart_0

components_charts_MarginsChart_18
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_10y

  • components_charts_BaseChart_0

  • chart_toolbar_max

components_charts_MarginsChart_15
components_charts_MarginsChart_17
components_charts_MarginsChart_16
components_charts_MarginsChart_19

Takeda Pharmaceutical Co components_charts_MarginsChart_21

Takeda Pharmaceutical Co components_charts_MarginsChart_15Takeda Pharmaceutical Co components_charts_MarginsChart_16Takeda Pharmaceutical Co components_charts_MarginsChart_17Takeda Pharmaceutical Co components_charts_MarginsChart_16
2028e65,51 %0 %0 %
2027e65,51 %10,86 %6,19 %
2026e65,51 %8,73 %5,08 %
202565,51 %7,48 %2,36 %
202466,54 %10,10 %3,38 %
202369,11 %13,68 %7,87 %
202268,99 %15,28 %6,45 %
202168,91 %10,50 %11,76 %
202066,89 %8,71 %1,34 %
201968,92 %8,75 %6,45 %
201871,99 %11,46 %10,56 %
201767,74 %11,04 %6,64 %
201670,38 %8,14 %4,44 %
201570,70 %4,99 %-8,20 %
201471,02 %8,97 %6,30 %
201371,26 %7,87 %8,43 %
201271,29 %17,56 %8,23 %
201177,63 %25,86 %17,46 %
201080,55 %28,66 %20,31 %
200981,18 %19,92 %15,24 %
200879,73 %30,78 %25,85 %
200778,57 %35,13 %25,73 %
200676,73 %33,23 %25,81 %

Takeda Pharmaceutical Co Aktienanalyse

pages_kennzahlen_[key]_[isin]__1

Takeda Pharmaceutical Co Ltd is a Japanese company that operates in the pharmaceutical industry. The company was founded in 1781 by Chobei Takeda as a traditional pharmacy specializing in herbal medicine. Nowadays, the company is a leading player in the global pharmaceutical industry. Business model: Takeda aims to help people worldwide through the development of groundbreaking therapies and drugs. The company has a strong research and development department that focuses on the discovery of new therapies and the improvement of existing medications. Takeda has made global partnerships and acquisitions to leverage the combination of science and technology and ensure better patient care. Divisions: Takeda operates in four main divisions: Gastrointestinal (GI), Oncology, Rare Diseases, and Neuroscience. In the GI division, the company is a global leader in the treatment of gastrointestinal diseases such as Crohn's disease and ulcerative colitis. The Oncology division aims to develop novel cancer therapies and provide patients with a higher quality of life. The Rare Diseases division specializes in the development of medications for rare diseases. The Neuroscience division focuses on developing medications to combat nervous system disorders such as Alzheimer's and Parkinson's. Products: Takeda's product range includes a variety of medications used worldwide to treat various diseases. One example is enzyme replacement therapy, which is administered to patients with a rare disease. Another example is Entyvio, a medication used to treat Crohn's disease and ulcerative colitis. Takeda also has medications in the Oncology division, such as Adcetris, a therapeutic agent against certain lymphomas and leukemia. In summary, Takeda Pharmaceutical Co Ltd is a leading company in the global pharmaceutical industry. The company's business model is based on the development of groundbreaking therapies and medications to improve patient care. With a focus on the GI, Oncology, Rare Diseases, and Neuroscience divisions, Takeda offers a variety of products for the treatment of various diseases. Takeda Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

pages_kennzahlen_[key]_[isin]__85

pages_kennzahlen_[key]_[isin]__71

pages_dividenden_[isin]_index__2

components_kpi_RevenueFaqs_0

components_kpi_RevenueFaqs_1

components_kpi_RevenueFaqs_2

components_kpi_RevenueFaqs_3

components_kpi_RevenueFaqs_4

components_kpi_RevenueFaqs_5

components_kpi_RevenueFaqs_6

components_kpi_RevenueFaqs_7

components_kpi_RevenueFaqs_8

components_kpi_RevenueFaqs_9

components_kpi_RevenueFaqs_10

components_kpi_RevenueFaqs_11

components_kpi_RevenueFaqs_12

components_kpi_RevenueFaqs_13

components_kpi_RevenueFaqs_14

components_kpi_RevenueFaqs_15

components_kpi_RevenueFaqs_16

components_kpi_RevenueFaqs_17

pages_aktie_[isin]_[key]_index_0

pages_aktie_[isin]_[key]_index_1

pages_aktie_[isin]_[key]_index_2

pages_aktie_[isin]_[key]_index_3

pages_aktie_[isin]_[key]_index_4

pages_aktie_[isin]_[key]_index_5

pages_aktie_[isin]_[key]_index_6

pages_aktie_[isin]_[key]_index_7

pages_aktie_[isin]_[key]_index_8

pages_aktie_[isin]_[key]_index_9

pages_aktie_[isin]_[key]_index_10

pages_aktie_[isin]_[key]_index_14

Wann musste ich die Aktien von Takeda Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

pages_aktie_[isin]_[key]_index_15

pages_aktie_[isin]_[key]_index_16

pages_aktie_[isin]_[key]_index_18

pages_aktie_[isin]_[key]_index_19

pages_aktie_[isin]_[key]_index_20

pages_aktie_[isin]_[key]_index_21

pages_aktie_[isin]_[key]_index_22

components_kpi_Savingsplan_0

components_kpi_Savingsplan_3